In my November 3, 2024 Thermo Fisher Scientific (TMO) post, I stated 'I think there will be an opportunity to acquire shares at a more favorable valuation within the next 12 months'. TMO shares were trading @ ~$558. Within days of that post, TMO's share price plunged thus contributing to an improvement in its valuation. [...]
A strong case for investing in BlackRock (BLK) can be made when markets implode. It is the world's largest asset manager with over $11.5 TRILLION of Assets Under Management (AUM). In prior Brookfield (BN.to), Blackstone (BX), and BlackRock (BLK) posts, I stated that the asset management industry is saturated and that a 'shake-out' is imminent. [...]
In my recent Corrections Are Healthy post, I reference Rudyard Kipling's poem 'If'. I mention that the segments from the poem that resonate the most with me are: If you can keep your head when all about you are losing theirs If you can wait and not be tired by waiting After publishing that post [...]
To the best of my ability, I try to provide the timely disclosure of my investment activity. In my April 3 Blackstone and Brookfield Exposure Increase post, I disclose purchases in those two companies. With the April 7 Mastercard (MA), S&P Global (SPGI), and HEICO Corporation (HEI and HEI.a) exposure increases, I now disclose these [...]
Some investors perform discounted cash flow analyses when trying to assess a company’s outlook. Perhaps these calculations help them justify their investment decisions. I, however, get absolutely no value from performing these calculations and came to this realization in the mid-1980s while attending a Master of Business Administration (MBA) program at university. My finance professors [...]
We are certainly living in 'interesting times'. As investors, we can either 'panic' or view them as an 'opportunity'. I view the April 2 tariff announcement as an 'opportunity'. A HUGE segment of the global population is, unfortunately, going to be in a 'world of hurt'. The same applies to a great many companies whose [...]
In my December 19, 2024 post I disclose initiating a 300 share Cintas (CTAS) position in one of the 'Side' accounts in the FFJ Portfolio. I subsequently acquired an additional 200 shares on December 31, 2024 thereby bringing my total exposure to 500 shares. Although CTAS is in an entirely different industry than Rollins (ROL), [...]
Another month has flown by thus triggering this FFJ Portfolio - March 2025 report; all monthly reports are accessible here. At the end of every post, I include the 'I do not know your circumstances and am not providing individualized advice or recommendations' disclaimer. I want to ensure everyone reading my posts has no preconceived [...]
Following my October 2, 2024 post at which time the most currently available financial information was for Q1 2025, Paychex (PAYX) disclosed its intent to acquire Paycor HCM (PYCR) for ~$4.1B on January 7, 2025. PAYX expects to close this acquisition in April 2025. This impending acquisition makes strategic sense as it enables PAYX to expand [...]
Invest in a business any fool can run, because someday a fool will. Charlie Munger and Warren Buffett - Berkshire Hathaway Nike (NKE) is a good example of how poor leadership can harm even great companies! When John Donahoe was appointed as NKE's 4th CEO in January 2020, NKE called out his 'expertise in digital [...]